NCT02754544 Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
| NCT ID | NCT02754544 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Brain Neoplasm |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2016-07-22 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2016-07-22 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot clinical trial studies how well electrocorticography works in mapping functional brain areas during surgery in patients with brain tumors. Using a larger than the standard mapping grid currently used during brain tumor surgery or a high-definition grid for electrocorticogram brain mapping may help doctors to better identify which areas of the brain are active during specific limb movement and speech during surgery in patients with brain tumors.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing a tumor resection at the University of Texas M. D. Anderson Cancer Center for a newly diagnosed as well as recurrent primary or metastatic brain tumor located in or adjacent to motor and/or speech brain areas * Patients \>= 18 years of age * Signed informed consent Exclusion Criteria: * Patients with significant neurological motor deficits of the upper extremities, and/or speech deficits, which would preclude them from performing the while awake intra-operative tasks at the discretion of the principal investigator (PI) * Patients who have impaired vision and/or hearing and whose performance could affect the study will be excluded at the discretion of the PI
Contact & Investigator
Sujit S Prabhu
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT02754544 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Brain Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02754544 currently recruiting?
Yes, NCT02754544 is actively recruiting participants. Contact the research team at sprabhu@mdanderson.org for enrollment information.
Where is the NCT02754544 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT02754544 clinical trial?
NCT02754544 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Sujit S Prabhu at M.D. Anderson Cancer Center. The trial plans to enroll 75 participants.